Compounds > hydralazine
Page last updated: 2024-10-28

hydralazine and Benign Neoplasms, Brain

hydralazine has been researched along with Benign Neoplasms, Brain in 3 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wehner, RJ1
Romanauskas, VS1
James, DJ1
Bedford, RF1
Kaufmann, W1

Other Studies

3 other studies available for hydralazine and Benign Neoplasms, Brain

ArticleYear
An adverse reaction with hydralazine: a case study.
    AANA journal, 1981, Volume: 49, Issue:3

    Topics: Blood Pressure; Bradycardia; Brain Neoplasms; Frontal Lobe; Glioblastoma; Humans; Hydralazine; Injec

1981
Hydralazine for controlled hypotension during neurosurgical operations.
    Anesthesia and analgesia, 1982, Volume: 61, Issue:12

    Topics: Adult; Arteriovenous Malformations; Brain Neoplasms; Enflurane; Humans; Hydralazine; Hypotension, Co

1982
[Principles of hypertension therapy].
    Munchener medizinische Wochenschrift (1950), 1967, Apr-21, Volume: 109, Issue:16

    Topics: Adult; Antihypertensive Agents; Aortic Valve Stenosis; Brain Neoplasms; Cushing Syndrome; Diagnosis,

1967